Sid Mukherjee (Photo by Brian Ach/Getty Images for The New Yorker)

J&J, Sid Mukher­jee's Vor team up to pair bis­pecifics with en­gi­neered stem cells for blood can­cer

J&J is one of many Big Phar­ma drug­mak­ers chas­ing the gold­en goose in on­col­o­gy bis­pecifics, with some ear­ly pos­i­tive re­sults in lung can­cer to show …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.